Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market and Technology Background
- Introduction
- In vitro Diagnostics Technology
- Overview
- Classification of In Vitro Diagnostic Elements
- Importance of In Vitro Diagnostics Technologies and Quality Control
- Difference Between In Vitro and In Vivo Diagnostics
- Regulations in the IVD Industry
- Regulation of IVD Products in Different Countries
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Rise in Population of Older Adults: Dependence on Diagnosis Procedures
- Integration of Artificial Intelligence in Vitro Diagnostics
- Rising Prevalence of Chronic Diseases
- Improving the Quality of Point-of-Care Testing (POCT)
- Market Restraints
- Challenges Associated with Technologies Product Packaging
- Increases in Shipping Costs or Service Issues
- Laboratory Assistant's Inability to Handle Laboratory Equipment and Consumables
- Market Opportunities
- Rise in Home Care Testing Devices
- Demand for Point-of-Care (POC) Testing Units
- Growing Demand for AI and the Internet of Things
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies in the IVD Market
- Artificial Intelligence
- Modified Old IVD Techniques
- Liquid Biopsy
- Automated In Vitro Diagnostic Devices
- Emerging Developments in In Vitro Diagnostics
- FDA Approval
- Rise in Demand for Personalized Medicine
- Lab Automation and Digital Health Platform
- Portability Option in IVD Devices
- Home Care Kits for Cancer Diagnosis
- FDA Approved In Vitro Diagnostic Devices: AI Enabled
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis by Technology
- Immunochemistry
- POC Testing
- Hematology
- Molecular Diagnostics
- Tissue Diagnostics
- Clinical Microbiology
- Market Analysis by Application
- Diabetes
- Nephrology
- Blood Glucose Evaluation and Monitoring (BGEM)
- Oncology
- Cardiology
- Infectious Diseases
- Other Applications
- Market Analysis by End User
- Diagnostic Laboratory
- Hospitals and Clinics
- Point-of-Care (POC) Centers
- Other End Users
- Geographical Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Chapter 6 Competitive Intelligence
- Introduction
- Global Analysis of Company Market Ranking
- Glimpse of Leading In Vitro Diagnostics (IVD) Companies in China
- Agreements, Collaborations and Partnerships
- bioMérieux Agreements
- Siemens Healthineers and Sysmex Enter into a Global Agreement
- Roche Enters into Agreement with Path AI
- Quidel Corp. Signs Agreement to Acquire Ortho Clinical Diagnostics
- In Vitro Diagnostics Companies and Start-Ups in 2021-2023
- Diagopreutic Private Limited
- Diatherax
- IPLEXMED
- Magnify Bioscience Inc.
Chapter 7 Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
- Importance of ESG in In Vitro Diagnostics Manufacturing Industry
- ESG Practices in the In Vitro Diagnostics Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Company Role in ESG Development
- ESG Risk Ratings
- BCC Research Viewpoint
List of Tables
Summary Table: Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 1: Approved FDA In Vitro Diagnostics Devices, 2021-2024
Table 2: Differences Between In Vitro and In Vivo Diagnostics
Table 3: FDA Approval of Artificial Intelligence and Machine Learning-Enabled Medical Devices, 2024
Table 4: Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 5: Global Market for In Vitro Diagnostics in Immunochemistry, by Region, Through 2029
Table 6: Global Market for In Vitro Diagnostics in POC Testing, by Region, Through 2029
Table 7: Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
Table 8: Global Market for In Vitro Diagnostics in Hematology, by Region, Through 2029
Table 9: Global Market for In Vitro Diagnostics in Molecular Diagnostics, by Region, Through 2029
Table 10: Global Market for In Vitro Diagnostics in Tissue Diagnostics, by Region, Through 2029
Table 11: Global Market for In Vitro Diagnostics in Clinical Microbiology, by Region, Through 2029
Table 12: Global Market for In Vitro Diagnostics, by Application, Through 2029
Table 13: Global Market for Diabetes in In Vitro Diagnostics, by Region, Through 2029
Table 14: Global Market for Nephrology in In Vitro Diagnostics, by Region, Through 2029
Table 15: Global Market for BGEM in In Vitro Diagnostics, by Region, Through 2029
Table 16: Global Market for Oncology in In Vitro Diagnostics, by Region, Through 2029
Table 17: Global Market for Cardiology in In Vitro Diagnostics, by Region, Through 2029
Table 18: Global Market for Infectious Diseases in In Vitro Diagnostics, by Region, Through 2029
Table 19: Global Market for Other Applications in In Vitro Diagnostics, by Region, Through 2029
Table 20: Global Market for In Vitro Diagnostics, by End User, Through 2029
Table 21: Global Market for In Vitro Diagnostics for Diagnostic Laboratory, by Region, Through 2029
Table 22: Global Market for In Vitro Diagnostics for Hospitals and Clinics, by Region, Through 2029
Table 23: Global Market for In Vitro Diagnostics for Point-of-Care Centers, by Region, Through 2029
Table 24: Global Market for In Vitro Diagnostics for Other End Users, by Region, Through 2029
Table 25: Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 26: North American Market for In Vitro Diagnostics, by Country, Through 2029
Table 27: European Market for In Vitro Diagnostics, by Country, Through 2029
Table 28: Asia-Pacific Market for In Vitro Diagnostics, by Country, Through 2029
Table 29: Latin American Market for In Vitro Diagnostics, by Sub-Region, Through 2029
Table 30: Total Imports of Medical Equipment into Brazil, 2021 and 2022
Table 31: Middle Eastern and African Market for In Vitro Diagnostics Technology, by Sub-Region, Through 2029
Table 32: bioMérieux Agreements
Table 33: ESG Practices: Environmental Performance
Table 34: ESG Practices: Social Performance
Table 35: ESG Practices: Governance Performance
Table 36: Creating an Attractive Workplace: Social Performance
Table 37: ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
Table 38: Abbott: Company Snapshot
Table 39: Abbott: Financial Performance, FY 2022 and 2023
Table 40: Abbott: Product Portfolio
Table 41: Abbott: News/Key Developments, 2022-2024
Table 42: BD: Company Snapshot
Table 43: BD: Financial Performance, FY 2022 and 2023
Table 44: BD: Product Portfolio
Table 45: BD: News/Key Developments, 2022-2024
Table 46: BIOMÉRIEUX: Company Snapshot
Table 47: BIOMÉRIEUX: Financial Performance, FY 2022 and 2023
Table 48: BIOMÉRIEUX: Product Portfolio
Table 49: BIOMÉRIEUX: News/Key Developments, 2023 and 2024
Table 50: Bio-Rad Laboratories Inc.: Company Snapshot
Table 51: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 52: Bio-Rad Laboratories Inc.: Product Portfolio
Table 53: Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 54: Bio-Techne: Company Snapshot
Table 55: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 56: Bio-Techne: Product Portfolio
Table 57: Bio-Techne: News/Key Developments, 2022 and 2023
Table 58: Bruker: Company Snapshot
Table 59: Bruker: Financial Performance, FY 2022 and 2023
Table 60: Bruker: Product Portfolio
Table 61: Bruker: News/Key Developments, 2021-2024
Table 62: Danaher Corp.: Company Snapshot
Table 63: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 64: Danaher Corp.: Product Portfolio
Table 65: Danaher Corp.: News/Key Developments, 2021-2023
Table 66: EKF Diagnostics Holdings plc.: Company Snapshot
Table 67: EKF Diagnostics Holdings plc.: Financial Performance, FY 2022 and 2023
Table 68: EKF Diagnostics Holdings plc.: Product Portfolio
Table 69: EKF Diagnostics Holdings plc.: News/Key Developments, 2022-2024
Table 70: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 71: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 72: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 73: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 74: Hologic Inc.: Company Snapshot
Table 75: Hologic Inc.: Financial Performance, FY 2022 and 2023
Table 76: Hologic Inc.: Product Portfolio
Table 77: Hologic Inc.: News/Key Developments, 2022-2024
Table 78: JSR Corp.: Company Snapshot
Table 79: JSR Corp.: Financial Performance, FY 2022 and 2023
Table 80: JSR Corp.: Product Portfolio
Table 81: JSR Corp.: News/Key Developments, 2024
Table 82: QuidelOrtho Corp.: Company Snapshot
Table 83: QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 84: QuidelOrtho Corp.: Product Portfolio
Table 85: QuidelOrtho Corp.: News/Key Developments, 2021-2024
Table 86: Siemens Healthineers AG: Company Snapshot
Table 87: Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 88: Siemens Healthineers AG: Product Portfolio
Table 89: Siemens Healthineers AG: News/Key Developments, 2021-2024
Table 90: Sysmex Corp.: Company Snapshot
Table 91: Sysmex Corp.: Financial Performance, FY 2022 and 2023
Table 92: Sysmex Corp.: Product Portfolio
Table 93: Sysmex Corp.: News/Key Developments, 2022 and 2023
Table 94: Thermo Fisher Scientific Inc.: Company Snapshot
Table 95: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 96: Thermo Fisher Scientific Inc.: Product Portfolio
Table 97: Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
List of Figures
Summary Figure: Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 1: Snapshot of Market Dynamics
Figure 2: Older Adults Using Technology to Manage Chronic Health Issues in the U.S., by Age Group, 2024
Figure 3: Percentage of People Aged 50+ Using Digital Services in the U.S., 2024
Figure 4: Breakdown of Global Elderly Population (Aged 65+ Years), by Select Countries, 2022
Figure 5: Emerging AI Applications in In Vitro Diagnostics
Figure 6: Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 7: Global Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 8: Snapshot of IVD Tests in Oncology
Figure 9: Global Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 10: Global Market Shares of In Vitro Diagnostics, by Region, 2023
Figure 11: North American Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 12: North American Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 13: North American Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 14: North American Market Shares of In Vitro Diagnostics, by Country, 2023
Figure 15: European Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 16: European Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 17: European Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 18: European Market Shares of In Vitro Diagnostics, by Sub-Region , 2023
Figure 19: Asia-Pacific Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 20: Asia-Pacific Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 21: Asia-Pacific Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 22: Asia-Pacific Market Shares of In Vitro Diagnostics, by Country, 2023
Figure 23: Latin American Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 24: Latin American Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 25: Latin American Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 26: Latin American Market Shares of In Vitro Diagnostics, by Sub-Region, 2023
Figure 27: Middle Eastern and African Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 28: Middle Eastern and African Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 29: Middle Eastern and African Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 30: Middle Eastern and African Market Shares of In Vitro Diagnostics, by Sub-Region, 2023
Figure 31: Rankings of Leading Companies in Global In Vitro Diagnostics Market, 2023
Figure 32: Snapshot: Key ESG Trends in the In Vitro Diagnostics Industry
Figure 33: Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 34: Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 35: BD: Revenue Shares, by Business Unit, FY 2023
Figure 36: BD: Revenue Shares, by Country/Region, FY 2023
Figure 37: BIOMÉRIEUX: Revenue Shares, by Business Unit, FY 2023
Figure 38: BIOMÉRIEUX: Revenue Shares, by Country/Region, FY 2023
Figure 39: Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40: Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 41: Bio-Techne: Revenue Shares, by Business Unit, FY 2023
Figure 42: Bio-Techne: Revenue Shares, by Country/Region, FY 2023
Figure 43: Bruker: Revenue Shares, by Business Unit, FY 2023
Figure 44: Bruker: Revenue Shares, by Country/Region, FY 2023
Figure 45: Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 46: Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 47: EKF Diagnostics Holdings plc.: Revenue Shares, by Business Unit, FY 2023
Figure 48: EKF Diagnostics Holdings plc.: Revenue Shares, by Country/Region, FY 2023
Figure 49: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 50: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 51: Hologic Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 52: Hologic Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 53: JSR Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 54: JSR Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 55: QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 56: QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 57: Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023
Figure 58: Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023
Figure 59: Sysmex Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 60: Sysmex Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 61: Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 62: Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
